ALPS Medical Breakthroughs ETF
SBIO
56 hedge funds and large institutions have $43.4M invested in ALPS Medical Breakthroughs ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 10 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
4.57% less ownership
Funds ownership: 37.38% → 32.8% (-4.6%)
15% less funds holding
Funds holding: 66 → 56 (-10)
36% less capital invested
Capital invested by funds: $67.5M → $43.4M (-$24.2M)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
+$772K |
| 2 |
SFS
Strategic Financial Services
Utica,
New York
|
+$763K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$549K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$253K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$234K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$4.65M |
| 2 |
MC
Matisse Capital
Portland,
Oregon
|
-$2.54M |
| 3 |
Morgan Stanley
New York
|
-$1.98M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.97M |
| 5 |
LPL Financial
San Diego,
California
|
-$551K |
SBIO Hedge Fund Activity: Q1 2022 in Review
56 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2022, worth a combined $43.4M — down 36% from $67.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of SBIO and 3 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 15 added.
The largest buyer was Stifel Financial, adding an estimated $772K. The largest seller was Phoenix Financial, cutting an estimated $4.65M.
- 56 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2022, down from 66 in Q4 2021.
- Funds reported $43.4M of ALPS Medical Breakthroughs ETF stock for Q1 2022, down 36% quarter-over-quarter.
- 3 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2022 and 10 closed out, a net change of -7 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q1 2022 was Stifel Financial, an estimated $772K added.
- The largest ALPS Medical Breakthroughs ETF seller in Q1 2022 was Phoenix Financial, an estimated $4.65M sold.
Based on aggregated 13F filings for Q1 2022.